Person subject to the notification requirement
Name: Söderström, Daniela
Position: Other senior manager
Issuer: Biohit Plc
LEI: 74370089ATTSNBXJVT29
Notification type: INITIAL NOTIFICATION
Reference number: 74370089ATTSNBXJVT29_20190603065401_4
Transaction date: 2019-05-29
Instrument type: SHARE
ISIN: FI0009005482
Nature of the transaction: SUBSCRIPTION
(X) Linked to stock option programme
Transaction details
(1): Volume: 25 000 Unit price: 2.2766 EUR
Aggregated transactions
(1): Volume: 25 000 Volume weighted average price: 2.2766 EUR
Biohit Oyj
Semi Korpela
CEO
For additional information:
CEO Semi Korpela,
Biohit Oyj
tel +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com